Table 2 HLA class II allele distribution in GBS patients and healthy controls

AlleleGBS patients, n = 164 n (%)Controls, n = 207 n (%)OR (95% CI)
HLA = human leukocyte antigen; GBS = Guillain-Barré syndrome; OR = odds ratio.
DRB1*0135 (21)41 (20)1.1 (0.7–1.8)
DRB1*0338 (23)63 (30)0.7 (0.4–1.1)
DRB1*0456 (34)58 (28)1.3 (0.9–2.1)
DRB1*0733 (20)42 (20)1.0 (0.6–1.6)
DRB1*0811 (7)11 (5)1.3 (0.6–3.0)
DRB1*096 (4)5 (2)1.5 (0.5–4.8)
DRB1*104 (2)7 (3)0.8 (0.2–2.5)
DRB1*1120 (12)35 (17)0.7 (0.4–1.2)
DRB1*126 (4)3 (1)2.4 (0.6–8.9)
DRB1*1342 (26)46 (22)1.2 (0.7–1.9)
DRB1*1418 (11)9 (4)2.6 (1.2–5.9)
DRB1*1538 (23)64 (31)0.7 (0.4–1.1)
DRB1*162 (1)7 (3)0.4 (0.1–1.7)
DQB1*0255 (34)84 (41)0.7 (0.5–1.1)
DQB1*0392 (56)102 (49)1.3 (0.9–2.0)
DQB1*049 (5)10 (5)1.1 (0.5–2.8)
DQB1*0556 (34)65 (31)1.1 (0.7–1.8)
DQB1*0674 (45)96 (46)1.0 (0.6–1.4)